Parade on MSN3 小时
'I Was Diagnosed With Stage IV Ovarian Cancer At 58—Here's What I Noticed FIrst'
She had stage IV ovarian cancer, and her chances of survival were grim. This September, more than 10 years later, Polo ...
Rolling Out11 小时
Lymphoma’s impact on Black men’s health
Lymphoma, a cancer of the immune system, is silently ravaging the health of Black men across America. This insidious disease, ...
Armed robbery in Revesby12 小时
Surgical Advances Tailor Breast Cancer Care, Boost Quality
Dr. Sarah McLaughlin in surgeryOctober is Breast Cancer Awareness MonthJACKSONVILLE, Florida - There are two surgical options ...
Sarasota Memorial Research Institute Participates In Groundbreaking Prostate Cancer Imaging ...
Sarasota Memorial Research Institute remains committed to advancing medical research and improving patient care through ...
'GPs failed to diagnose my daughter’s cancer 20 times - she was only 27 years old'
Early cancer diagnosis is key to survival. By the time Jessica got her diagnosis via a private referral, it was too late ...
EXCLUSIVE: Jenna Fischer recalls moment she learned about her breast cancer diagnosis
Just over a week after Jenna Fischer publicly revealed her breast cancer diagnosis, the former “The Office” actor is opening ...
The Nassau Guardian12 小时
Early detection and informed decision-making remain the cornerstones of successful breast ...
Breast cancer is a major global health issue, with 2.3 million new cases in 2022. In The Bahamas, the situation is particularly alarming, as 300 to 500 women are diagnosed ...
Family's heartbreak as daughter, 27, died after GPs missed her cancer 20 times
Jessica Brady was just 27 when she died from cancer - her family has been left heartbroken and now campaigns for 'Jessica's Law' ...
National Institute for Health and Care Excellence23 小时
Breast cancer
Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.
TCBP Enters Research Planning Collaboration with Dr. Carlos Maluquer de Motes for Mpox ...
PLC ("TC BioPharm" or the "Company") (NASDAQ: TCBP), a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today ...